News
October 7, 2026
International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease
Biohub, the U.S. Department of Energy, the National Institutes of Health, and new funding partners today announced a major expansion of an international effort to generate and make accessible the data enabling predictive AI models of …
-
Biohub’s Residency Program: Pushing the Frontiers of Imaging, Together
Experts in advanced light microscopy, cryo-ET, computational imaging, and other measurement modalities collaborate with Biohub scientists to catalyze breakthroughs
-
Sepsis is linked to 11 million deaths a year. A new machine-learning platform could help catch it within minutes
A technology built by Biohub scientists uses artificial intelligence to recognize sepsis from images of millions of blood cells, without being told what to look for.
-
International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease
Biohub, the U.S. Department of Energy, the National Institutes of Health, and new funding partners today announced a major expansion of an international effort to generate and make accessible the data enabling predictive AI models of …
-
TIME: 100 AI List (2026)
Biohub Head of Science, Alex Rives, is named to the TIME100 AI list
-
Why one drug isn’t enough: AI reveals cancer’s secret weapon – and how to beat it
Tumors are patchworks of distinct malignant cell states, each with its own survival strategy. With AI, Biohub scientists are discovering drug combinations that defeat them all at once.
-
GEN: Virtual Cells Go Multiscale to Predict Complex Biology
AI models inform therapeutics that can restore diseased cells to healthy states
-
Protein Modeling, Cell Imaging and Patient-Powered Science: Reflections on Biohub’s Start to the Year
Co-founder Priscilla Chan shares reflections following Aspen Ideas: Health on the models, tools, and people driving Biohub's progress this year.
-
Surprising drug targets for psoriasis emerge from comprehensive CRISPR study of human skin cells
Analysis of results by AI ‘novelty filter’ led researchers to formulate topical gels that, in mice, were as effective as widely used injected therapy.
-
From patient communities to precision treatments: harnessing AI-powered biology for rare disease
-
Science: Laser-boosted microscopes could reveal new drug targets, sharpen views inside cells
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view
-
C&EN: A new, ultrabright laser powers a cryo-EM advance 15 years in the making
Phase contrast enables structures of smaller proteins, could drive in-cell proteomics
-
Making the invisible visible
A landmark achievement in microscopy is poised to reveal the molecular machinery of life inside cells, at near-atomic detail.